Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

Item
http://www.wikidata.org/entity/Q27022941
The future of high-grade glioma: Where we are and where are we going.Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma.15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Aminopyridyl/Pyrazinyl Spiro[indoline-3,4'-piperidine]-2-ones As Highly Selective and Efficacious c-Met/ALK Inhibitors.Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men.Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.
P2860

Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma

Item
http://www.wikidata.org/entity/Q27022941
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@ast
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@en
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@nl
type
label
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@ast
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@en
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@nl
prefLabel
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@ast
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@en
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P932
P356
P1433
P1476
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P932